Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.95
(
-0.04%
)
US TECH 100
26,674.80
(
1.42%
)
Dow Jones
48,861.81
(
-0.57%
)
Brent Oil
112.63
(
0.22%
)
Bitcoin
75,756.12
(
-0.03%
)
News Focus
News Focus
Post# of 27661
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Work Harder

Send PM Follow Ignore
Followers 99
Posts 13186
Boards Moderated 0
Alias Born 06/01/2013

Work Harder

Re: Work Harder post# 20382

Sunday, 09/27/2020 1:49:53 PM

Sunday, September 27, 2020 1:49:53 PM

Post# of 27661
The article Danish rare disease biotech Orphazyme files for a $115 million US IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

founded in 2009

https://www.nasdaq.com/articles/danish-rare-disease-biotech-orphazyme-files-for-a-%24115-million-us-ipo-2020-09-04

Whew Cow

https://www.renaissancecapital.com/IPO-Investing/Intl-IPO-ETF
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote